Skip to main content
. Author manuscript; available in PMC: 2013 Apr 4.
Published in final edited form as: Ann Intern Med. 2012 Feb 7;156(3):204–210. doi: 10.1059/0003-4819-156-3-201202070-00008

Table 1.

Patient characteristics according to cancer type. Data are given as frequency (percentage) unless otherwise specified.

Metastatic Lung Cancer Metastatic Colorectal Cancer
Number of patients 1535 620
Sex3
   Male 952 (62) 368 (59)
   Female 583 (38) 252 (41)
Race3
   White 1210 (79) 413 (67)
   Black 170 (11) 121 (20)
   Asian 83 (5) 37 (6)
   Other 69 (4) 47 (8)
   Missing 3 (0.2) 2 (0.3)
Ethnicity3
   Hispanic 76 (5) 47 (8)
   Non-Hispanic 1442 (94) 562 (91)
   Missing 17 (1) 11 (2)
Marital status3
   Married/living as married 917 (60) 369 (60)
   Non-married 607 (40) 246 (40)
   Missing 11 (1) 5 (1)
Age (years)3
   21-54 193 (13) 151 (24)
   55-59 187 (12) 73 (12)
   60-64 204 (13) 83 (13)
   65-69 245 (16) 85 (14)
   70-74 276 (18) 77 (12)
   75-79 214 (14) 51 (8)
   ≥ 80 216 (14) 100 (16)
Comorbidity score at diagnosis*2
   None 312 (20) 194 (31)
   Mild 576 (38) 240 (39)
   Moderate 328 (21) 109 (18)
   Severe 319 (21) 77 (12)
Number of hospitalizations in 90 days
before diagnosis2
   0 963 (63) 393 (63)
   1 497 (32) 203 (33)
   2 to 4 75 (5) 24 (4)
Speaks English in home1
   Yes 1397 (91) 541 (87)
   No 51 (3) 30 (5)
   Missing 87 (6) 49 (8)
Education1
   < High school 352 (23) 105 (17)
   High school/some college 902 (59) 361 (58)
   ≥ college degree 252 (16) 145 (23)
   Missing 29 (2) 9 (1)
Income ($)1
   < 20,000 460 (30) 161 (26)
   20,000-39,999 428 (28) 142 (23)
   40,000-59,999 184 (12) 78 (13)
   ≥ 60,000 215 (14) 118 (19)
   Missing 248 (16) 121 (20)
Insurance3
   Medicare 220 (14) 82 (13)
   Medicaid 179 (12) 78 (13)
   Medicare + Private 566 (37) 166 (27)
   Private 383 (25) 218 (35)
   Other 179 (12) 73 (12)
   Missing 8 (1) 3 (0.5)
HMO member4
   Yes 412 (27) 158 (25)
   No 1123 (73) 462 (75)
PDCR Site4
   Cancer Research Network 246 (16) 92 (15)
   Northern California 324 (21) 157 (25)
   Alabama 188 (12) 99 (16)
   Los Angeles 248 (16) 112 (18)
   Iowa 361 (24) 0 (0)
   North Carolina 0 (0) 97 (16)
   Veterans Administration 168 (11) 63 (10)
Months from diagnosis to baseline
interview
   Median (interquartile range) 5 (4, 7) 5 (4, 6)
   Range 0, 25 2, 27
Baseline interview completed
   Patient 522 (34) 357 (58)
   Brief 130 (8) 73 (12)
   By surrogate: patient too sick 134 (9) 56 (9)
   By surrogate: patient deceased 749 (49) 134 (22)
Followup interview completed**
   Survivor 252 (32) 270 (56)
   Decedent: by surrogate 288 (37) 82 (17)
   Not completed: patient alive at
   baseline
246 (31) 134 (28)
Vital status at end of abstraction period
   Alive 322 (21) 363 (59)
   Dead 1213 (79) 257 (41)
Median survival, months
   (25th percentile, 75th percentile) 6
(2, 13)
20
(7, 46)

PDCR: Primary Data Collection and Research

*

Defined using the Adult Comorbidity Evaluation 27, a validated medical record-based system that assigns each patient a 4-category comorbidity score (none, mild, moderate, or severe) based on severity noted across multiple body systems, from 3 months prior to diagnosis to initial treatment.

**

Among patients alive at baseline interview and thus eligible for followup interview.

1

Data obtained from baseline or follow-up interviews

2

Data obtained from medical record abstraction

3

Data obtained primarily from baseline interview; if non-response to interview item, then data obtained secondarily from medical record abstraction; if both data sources are missing, then data are obtained from the administrative data (or tracking records)

4

Data obtained from administrative data (or tracking records)